drugset / Trial / NCT05239013

Safety and Tolerability of Nitro for Radial Artery Dilation

NCT05239013

Phase 0 Unknown 20 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelOther

Summary

Phase 1, single-center, open-label clinical study to assess the safety and efficacy of topical nitroglycerin on dilation of the radial artery. Subjects will receive nitroglycerin ointment prior to scheduled PCI and radial artery measurements will be performed to determine mean increase in radial artery diameter at several time points. There will be 20 subjects enrolled in this study.

Timeline

Start
2022-05-01
Primary completion
2023-03-01
Completion
2023-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 2 % Topical
Subject Nitroglycerin Unknown 30 mg Topical

Indications